260 related articles for article (PubMed ID: 20049321)
21. Retinoblastoma tumor suppressor and genome stability.
Zheng L; Lee WH
Adv Cancer Res; 2002; 85():13-50. PubMed ID: 12374284
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth.
Aoki M; Morishita R; Matsushita H; Hayashi S; Nakagami H; Yamamoto K; Moriguchi A; Kaneda Y; Higaki J; Ogihara T
Hypertension; 1999 Aug; 34(2):192-200. PubMed ID: 10454440
[TBL] [Abstract][Full Text] [Related]
23. Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis.
Shinohara H; Zhou J; Yoshikawa K; Yazumi S; Ko K; Yamaoka Y; Mizukami T; Yoshida T; Akinaga S; Tamaoki T; Motoda H; Benedict WF; Takahashi R
Br J Cancer; 2000 Oct; 83(8):1039-46. PubMed ID: 10993652
[TBL] [Abstract][Full Text] [Related]
24. RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer.
Knudsen ES; McClendon AK; Franco J; Ertel A; Fortina P; Witkiewicz AK
Cell Cycle; 2015; 14(1):109-22. PubMed ID: 25602521
[TBL] [Abstract][Full Text] [Related]
25. Alterations in the tumor suppressor genes p53, RB, p16/MTS1, and p15/MTS2 in human pancreatic cancer and hepatoma cell lines.
Kaino M
J Gastroenterol; 1997 Feb; 32(1):40-6. PubMed ID: 9058294
[TBL] [Abstract][Full Text] [Related]
26. Incomplete inhibition of the Rb tumor suppressor pathway in the context of inactivated p53 is sufficient for pancreatic islet tumorigenesis.
Casanovas O; Hager JH; Chun MG; Hanahan D
Oncogene; 2005 Oct; 24(44):6597-604. PubMed ID: 16007165
[TBL] [Abstract][Full Text] [Related]
27. [Molecular cancer epidemiology--the present status and future possibilities].
Sakai T
Nihon Eiseigaku Zasshi; 1996 Feb; 50(6):1036-46. PubMed ID: 8720930
[TBL] [Abstract][Full Text] [Related]
28. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
29. ARF mutation accelerates pituitary tumor development in Rb+/- mice.
Tsai KY; MacPherson D; Rubinson DA; Nikitin AY; Bronson R; Mercer KL; Crowley D; Jacks T
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16865-70. PubMed ID: 12486224
[TBL] [Abstract][Full Text] [Related]
30. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
31. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.
Cesarman E; Chadburn A; Inghirami G; Gaidano G; Knowles DM
Blood; 1992 Dec; 80(12):3205-16. PubMed ID: 1361372
[TBL] [Abstract][Full Text] [Related]
32. Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.
Sharma A; Comstock CE; Knudsen ES; Cao KH; Hess-Wilson JK; Morey LM; Barrera J; Knudsen KE
Cancer Res; 2007 Jul; 67(13):6192-203. PubMed ID: 17616676
[TBL] [Abstract][Full Text] [Related]
33. Expression of oncogenes and tumor suppressor genes in lungs of rats exposed to sulfur dioxide and benzo(a)pyrene.
Qin G; Meng Z
Inhal Toxicol; 2010 Mar; 22(4):322-9. PubMed ID: 20064080
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.
Isakoff MS; Sansam CG; Tamayo P; Subramanian A; Evans JA; Fillmore CM; Wang X; Biegel JA; Pomeroy SL; Mesirov JP; Roberts CW
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17745-50. PubMed ID: 16301525
[TBL] [Abstract][Full Text] [Related]
35. [Mutations of several tumor suppressor genes in primary retinoblastoma].
Huang Q; Tao Y; Yandell DW
Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):10-2. PubMed ID: 11776785
[TBL] [Abstract][Full Text] [Related]
36. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents.
Hawkins DS; Demers GW; Galloway DA
Cancer Res; 1996 Feb; 56(4):892-8. PubMed ID: 8631030
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
[TBL] [Abstract][Full Text] [Related]
38. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
Inoue M
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
[TBL] [Abstract][Full Text] [Related]
39. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
[TBL] [Abstract][Full Text] [Related]
40. [Cell cycle, tumor suppressor genes and lung cancers].
Bréchot JM
Rev Mal Respir; 1998 Sep; 15(4):461-6. PubMed ID: 9805756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
